Dr. Coon Successfully Performs First-in-Human Flow Diversion Case at the Carondelet Neurological Institute in Tucson, Arizona

June 23, 2021 -Dr. Alexander Coon, one of the world’s leading cerebrovascular and endovascular neurosurgeons, successfully completed the the first in human implantation of the new Evolve 40-wire flow diversion device at the Carondelet Neurological Institute of St Joseph’s Hospital in Tucson, Arizona. This device is the first cobalt chromium flow diverter specifically designed to treat aneurysms of the distal circulation that usually would require open microsurgery (craniotomy). Its use was part of an ongoing FDA IDE trial (EVOLVE Study) running at 40 sites in the United States, Canada, and Australia. This was the only time in the past 15 years that a new brain stent was placed in a human for the first time here in the United States.